Axent Biotherapeutics
Axent Biosciences
- Website
- axentbio.com
- Last Round
- GrantDec 2022
- Rounds
- 1
About
Axent Biosciences develops next-generation cell therapies using engineered biomaterials. Its platform uses fully synthetic, biocompatible materials to create protective environments for cells, which it describes as a way to enable safer and more effective treatments. The company's research focuses on making these cell-therapy environments scalable.
Summary
Axent Biotherapeutics is a Biotech company. Its most recent funding was a Grant round in Dec 2022.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2022
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/axent-biotherapeutics"><img src="https://indexed.vc/api/badge/company/axent-biotherapeutics" alt="Axent Biotherapeutics on Indexed.vc" width="260" height="76" /></a>